Nu Skin Enterprises Inc
Suletud
7.35 0.55
Ülevaade
Aktsiahinna muutus
24h
Min
7.31
Max
7.47
Sissetulek | -2.6M 14M |
|---|---|
Müük | 6.1M 370M |
P/E Sektori keskmine | 2.26 19.47 |
Dividenditootlus | 3.34 |
Kasumimarginaal | 3.913 |
Töötajad | 2,800 |
EBITDA | 3.9M 36M |
Dividenditootlus Sektori keskmine | 3.34% 2.97% |
|---|---|
Järgmine tulemuste avaldamine | 7. mai 2026 |
Järgmine dividendimakse kuupäev | 10. juuni 2026 |
Järgmine aktsia dividendi kuupäev (ex-date) | 29. mai 2026 |
Turukapital | -130M 347M |
|---|---|
Eelmine avamishind | 6.8 |
Eelmine sulgemishind | 7.35 |
Tehniline skoor
By Trading Central
Kindlus
Bearish Evidence
Nu Skin Enterprises Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Nu Skin Enterprises Inc Prognoos
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Nu Skin Enterprises Inc
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.